These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 17768053)

  • 1. Computer-assisted image analysis of breast fine needle aspiration in a randomized chemoprevention trial of fenretinide vs. placebo in HRT users.
    Serrano D; Gandini S; Mariani L; Bonanni B; Santinelli A; Guerrieri-Gonzaga A; Pelosi G; Cassano E; Montironi R; Decensi A
    Breast; 2008 Feb; 17(1):91-7. PubMed ID: 17768053
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quality of life assessment in a chemoprevention trial: fenretinide and oral or transdermal HRT.
    Serrano D; Mariani L; Mora S; Guerrieri-Gonzaga A; Cazzaniga M; Daldoss C; Ramazzotto F; Feroce I; Decensi A; Bonanni B
    Maturitas; 2006 Aug; 55(1):69-75. PubMed ID: 16500052
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A two-by-two factorial trial comparing oral with transdermal estrogen therapy and fenretinide with placebo on breast cancer biomarkers.
    Decensi A; Bonanni B; Baglietto L; Guerrieri-Gonzaga A; Ramazzotto F; Johansson H; Robertson C; Marinucci I; Mariette F; Sandri MT; Daldoss C; Bianco V; Buttarelli M; Cazzaniga M; Franchi D; Cassano E; Omodei U
    Clin Cancer Res; 2004 Jul; 10(13):4389-97. PubMed ID: 15240527
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Digital image analysis of breast epithelial cells collected by random periareolar fine-needle aspirates (RPFNA) from women at high risk for breast cancer taking hormone replacement and the aromatase inhibitor, letrozole, for six months.
    Frank DH; Kimler BF; Fabian CJ; Ranger-Moore J; Yozwiak M; Bartels HG; Alberts DS; Bartels PH
    Breast Cancer Res Treat; 2009 Jun; 115(3):661-8. PubMed ID: 19125322
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Breast epithelial proliferation in postmenopausal women evaluated through fine-needle-aspiration cytology.
    Conner P; Skoog L; Söderqvist G
    Climacteric; 2001 Mar; 4(1):7-12. PubMed ID: 11379380
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Testosterone inhibits estrogen/progestogen-induced breast cell proliferation in postmenopausal women.
    Hofling M; Hirschberg AL; Skoog L; Tani E; Hägerström T; von Schoultz B
    Menopause; 2007; 14(2):183-90. PubMed ID: 17108847
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lowest effective transdermal 17beta-estradiol dose for relief of hot flushes in postmenopausal women: a randomized controlled trial.
    Bachmann GA; Schaefers M; Uddin A; Utian WH
    Obstet Gynecol; 2007 Oct; 110(4):771-9. PubMed ID: 17906008
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of transdermal estradiol and oral conjugated estrogen on C-reactive protein in retinoid-placebo trial in healthy women.
    Decensi A; Omodei U; Robertson C; Bonanni B; Guerrieri-Gonzaga A; Ramazzotto F; Johansson H; Mora S; Sandri MT; Cazzaniga M; Franchi M; Pecorelli S
    Circulation; 2002 Sep; 106(10):1224-8. PubMed ID: 12208797
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neutral effect of ultra-low-dose continuous combined estradiol and norethisterone acetate on mammographic breast density.
    Lundström E; Bygdeson M; Svane G; Azavedo E; von Schoultz B
    Climacteric; 2007 Jun; 10(3):249-56. PubMed ID: 17487652
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oral but not transdermal estrogen replacement therapy changes the composition of plasma lipoproteins.
    Vrablik M; Fait T; Kovar J; Poledne R; Ceska R
    Metabolism; 2008 Aug; 57(8):1088-92. PubMed ID: 18640386
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical trials with retinoids for breast cancer chemoprevention.
    Zanardi S; Serrano D; Argusti A; Barile M; Puntoni M; Decensi A
    Endocr Relat Cancer; 2006 Mar; 13(1):51-68. PubMed ID: 16601279
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of hormone replacement therapy on fine needle aspiration cytology of the breast.
    Carter N; Stephenson TJ; Silcocks PB; Shorthouse AJ
    Acta Cytol; 1995; 39(4):689-92. PubMed ID: 7631542
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Parallel assessment of the impact of different hormone replacement therapies on breast density by radiologist- and computer-based analyses of mammograms.
    Pettersen PC; Raundahl J; Loog M; Nielsen M; Tankó LB; Christiansen C
    Climacteric; 2008 Apr; 11(2):135-43. PubMed ID: 18365856
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A multicenter, prospective, randomized, double-blind, placebo-controlled study to investigate the efficacy of a continuous-combined hormone therapy preparation containing 1mg estradiol valerate/2mg dienogest on hot flushes in postmenopausal women.
    Endrikat J; Graeser T; Mellinger U; Ertan K; Holz C
    Maturitas; 2007 Oct; 58(2):201-7. PubMed ID: 17889463
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative effects of oral conjugated equine estrogens and micronized 17beta-estradiol on breast proliferation: a retrospective analysis.
    Wood CE; Clarkson TB; Chen H; Veenstra TD; Xu X; Scott L; Cline JM
    Menopause; 2008; 15(5):890-8. PubMed ID: 18520696
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of modified transdermal hormone replacement therapy on the concentrations of hormones, growth factors, and bone mineral density in women with osteopenia.
    Stanosz S; Zochowska E; Safranow K; Sieja K; Stanosz M
    Metabolism; 2009 Jan; 58(1):1-7. PubMed ID: 19059524
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of transdermal estradiol or oral conjugated oestrogen and fenretinide versus placebo on haemostasis and cardiovascular risk biomarkers in a randomized breast cancer chemoprevention trial.
    Lazzeroni M; Macis D; Decensi A; Gandini S; Sandri MT; Serrano D; Guerrieri-Gonzaga A; Johansson H; Mora S; Daldoss C; Omodei U; Bonanni B
    Ecancermedicalscience; 2008; 2():67. PubMed ID: 22275964
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of raloxifene and low-dose percutaneous 17beta-estradiol on menopause symptoms and endometrium--a randomized controlled trial.
    Valiati B; Capp E; Edelweiss MI; de Freitas FM; Wender MC
    Maturitas; 2009 Jan; 62(1):81-4. PubMed ID: 19097715
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Changes in hemostatic variables induced by estrogen replacement therapy: comparison of transdermal and oral administration in a crossover-designed study.
    Fait T; Vrablik M; Zizka Z; Kostirova M
    Gynecol Obstet Invest; 2008; 65(1):47-51. PubMed ID: 17713346
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of the route of estrogen administration on insulinlike growth factor-I, IGF binding protein-3, and insulin resistance in healthy postmenopausal women: results from a randomized, controlled study.
    Davis SR; Stuckey BG; Norman RJ; Papalia MA; Drillich A; Bell RJ
    Menopause; 2008; 15(6):1065-9. PubMed ID: 18806686
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.